1. Cytokine Response to SARS-CoV-2 Infection in Children
- Author
-
Antonio Gatto, Serena Ferretti, Antonio Chiaretti, G. Bersani, Lavinia Capossela, Antonietta Curatola, Alessandro Sgambato, and Donatella Lucchetti
- Subjects
Male ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Lymphocyte ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,medicine.medical_treatment ,Comorbidity ,Neutropenia ,Microbiology ,Severity of Illness Index ,Article ,TNF ,children ,Settore MED/04 - PATOLOGIA GENERALE ,Virology ,Internal medicine ,Severity of illness ,medicine ,Humans ,Interleukin 6 ,Child ,IL-6 ,biology ,business.industry ,SARS-CoV-2 ,Age Factors ,COVID-19 ,medicine.disease ,QR1-502 ,cytokines ,Infectious Diseases ,medicine.anatomical_structure ,Cytokine ,TNF-α ,Child, Preschool ,Host-Pathogen Interactions ,biology.protein ,Female ,business ,Biomarkers - Abstract
The causal connection between serum biomarkers and COVID-19 severity or pathogenicity in children is unclear. The aim of this study was to describe clinical and immunological features of children affected by COVID-19. The secondary aim was to evaluate whether these cytokines could predict severity of COVID-19. All children (aged 0−18) admitted to the Pediatric Emergency Department and tested with nasopharyngeal swab for SARS-CoV-2 were recruited and assigned to three groups: COVID-19, other infections, control group. Clinical and laboratory data of these patients, including circulating cytokine levels, were analyzed in three groups. Fever was the most frequent symptom in COVID-19 (67.3%). Neutropenia was found in the COVID-19 group (p <, 0.05), no difference was observed for lymphocyte counts in the three groups. Higher levels of IL-6 and TNF-alpha were found in the COVID-19 group compared to other infections and control groups (p = 0.014 and p = 0.001, respectively). Whereas, in the COVID-19 group, no difference was observed as for the same cytokines among sub-groups of different disease severity (p = 0.7 and p = 0.8). Serum levels of IL-6 and TNF-alpha were higher in COVID-19 children than in children with other infectious diseases, but those levels did not correlate with disease severity. Clinical studies in a large pediatric population are necessary to better define the role of the immune-mediated response in SARS-CoV-2 infections in children.
- Published
- 2021